Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay R Lieberman

Showing results (71-80 of 305) with videos related to

Pageof 31
Sort By:
The Journal of Arthroplasty|January 30, 2003
Patients' reasons for undergoing total hip arthroplasty can change over timeJay R Lieberman, Bert J Thomas, Gerald A m Finerman, et al.
The Journal of Arthroplasty|March 8, 2006
Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes?Nelson F Soohoo, David S Zingmond, Jay R Lieberman, et al.
The Journal of Arthroplasty|May 18, 2013
Is the pie-crusting technique safe for MCL release in varus deformity correction in total knee arthroplasty?R Michael Meneghini, Andrew T Daluga, Lindsey A Sturgis, et al.
Pharmaceutics|November 27, 2025
Modern Approaches and Emerging Biological Therapies to Treat Fracture NonunionJulian Wier, Hannah Shelby, Sarah Bergren, et al.
The Journal of Arthroplasty|August 2, 2023
Medical Weight Optimization for Arthroplasty Patients: A Primer of Emerging Therapies for the Joint Arthroplasty SurgeonCory K Mayfield, Michael A Mont, Jay R Lieberman, et al.
Instructional Course Lectures|April 15, 2003
Gene therapy in orthopaedic surgeryDavid Hannallah, Brett Peterson, Jay R Lieberman, et al.
The Journal of Bone and Joint Surgery. American Volume|March 3, 2006
Factors predicting complication rates following total knee replacementNelson F SooHoo, Jay R Lieberman, Clifford Y Ko, et al.
The Journal of Arthroplasty|August 16, 2017
Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic AnticoagulantsMark P Cote, Anthony Chen, Yue Jiang, et al.
Bioengineering (Basel, Switzerland)|February 27, 2026
The Osteoimmunologic Basis of Biologic and Bioengineered Scaffolds in Fracture HealingHannah Shelby, Sarah Bergren, Julian Wier, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|January 1, 2004
Genetically modified mesodermal-derived cells for bone tissue engineeringMichelle D Kofron, Jeffrey X Zhang, Jay R Lieberman, et al.
Pageof 31

Showing results (71-80 of 305) with videos related to

Sort By:
Pageof 31
The Journal of Arthroplasty|January 30, 2003
Patients' reasons for undergoing total hip arthroplasty can change over timeJay R Lieberman, Bert J Thomas, Gerald A m Finerman, et al.
The Journal of Arthroplasty|March 8, 2006
Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes?Nelson F Soohoo, David S Zingmond, Jay R Lieberman, et al.
The Journal of Arthroplasty|May 18, 2013
Is the pie-crusting technique safe for MCL release in varus deformity correction in total knee arthroplasty?R Michael Meneghini, Andrew T Daluga, Lindsey A Sturgis, et al.
Pharmaceutics|November 27, 2025
Modern Approaches and Emerging Biological Therapies to Treat Fracture NonunionJulian Wier, Hannah Shelby, Sarah Bergren, et al.
The Journal of Arthroplasty|August 2, 2023
Medical Weight Optimization for Arthroplasty Patients: A Primer of Emerging Therapies for the Joint Arthroplasty SurgeonCory K Mayfield, Michael A Mont, Jay R Lieberman, et al.
Instructional Course Lectures|April 15, 2003
Gene therapy in orthopaedic surgeryDavid Hannallah, Brett Peterson, Jay R Lieberman, et al.
The Journal of Bone and Joint Surgery. American Volume|March 3, 2006
Factors predicting complication rates following total knee replacementNelson F SooHoo, Jay R Lieberman, Clifford Y Ko, et al.
The Journal of Arthroplasty|August 16, 2017
Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic AnticoagulantsMark P Cote, Anthony Chen, Yue Jiang, et al.
Bioengineering (Basel, Switzerland)|February 27, 2026
The Osteoimmunologic Basis of Biologic and Bioengineered Scaffolds in Fracture HealingHannah Shelby, Sarah Bergren, Julian Wier, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|January 1, 2004
Genetically modified mesodermal-derived cells for bone tissue engineeringMichelle D Kofron, Jeffrey X Zhang, Jay R Lieberman, et al.
Pageof 31